Listen to the Story

The RV business is booming and shows no sign of slowing down. To find out why, our correspondent dragged his reluctant family to the RV capital of the world—the cutest city in north central Indiana!—and hit the road. By Patrick ClarkSee omnystudio.com/listener for privacy information.

David Neeleman, airline savant (think JetBlue) and perpetual optimist, is at it again with a new budget carrier called Breeze. By Drake BennettSee omnystudio.com/listener for privacy information.

Is the app that brought zero-commission trades and a mobile-first design to millions of investors too good at what it does? By Misyrlena Egkolfopoulou, Annie Massa, and Anders MelinSee omnystudio.com/listener for privacy information.

A December suicide sparked concern by employee representatives about the risk of more deaths. The bank says it’s focused on well-being. By Stephanie Bodoni and Gavin FrenchSee omnystudio.com/listener for privacy information.

Selling its Alaskan oil business last year was a green win for BP. But not for the planet. By Rachel Adams-HeardSee omnystudio.com/listener for privacy information.

While Amazon and its peers have stopped supporting certain prominent White supremacists and conspiracy theorists, Nick Lim has stepped in. By William Turton and Joshua BrusteinSee omnystudio.com/listener for privacy information.

The fast rise and even faster fall of a trader who bet big with borrowed money. By Erik Schatzker,Sridhar Natarajan, and Katherine BurtonSee omnystudio.com/listener for privacy information.

How Oxford and AstraZeneca's low-cost, not-for-profit Covid vaccine went from hope too hesitancy. By Stephanie Baker and Suzi RingSee omnystudio.com/listener for privacy information.

Companies and countries that depend on travel or large gatherings are counting on a totally unproven concept. By Christopher Jasper, Angus Whitley, and Eleni ChrepaSee omnystudio.com/listener for privacy information.

Vaccines are great and all, but molnupiravir, an antiviral drug in late-stage trials, could give doctors another major tool to end the pandemic—if, of course, it proves safe and effective. By Cynthia Koons and Riley GriffinSee omnystudio.com/listener for privacy information.